(Q45053410)

English

Comparison of 6-hydroxydopamine lesions of the substantia nigra and the medial forebrain bundle on a lateralised choice reaction time task in mice

scientific article published in November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Comparison of 6-hydroxydopamine lesions of the substantia nigra and the medial forebrain bundle on a lateralised choice reaction time task in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

substantia nigra

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Stephen Dunnett

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

object named as

Andreas Heuer

1

0 references

language of work or name

0 references

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

294-302

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Pathophysiology of bradykinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Initiation and execution of predictable and unpredictable movements in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Toxin-induced models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Striatal lesions produce distinctive impairments in reaction time performance in two different operant chambers

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Visuospatial function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in rats using a lateralised nose-poking task with low stimulus-response compatibility

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Cognitive components of reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Simple and choice reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Compulsive, Abnormal Walking Caused by Anticholinergics in Akinetic, 6-Hydroxydopamine-Treated Rats

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12036

21 January 2018

Identifiers

10.1111/EJN.12036

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45053410&oldid=2063995745"